141 related articles for article (PubMed ID: 30741550)
1. Graphene Oxide Nanoplatelets Potentiate Anticancer Effect of Cisplatin in Human Lung Cancer Cells.
Rosli NF; Fojtů M; Fisher AC; Pumera M
Langmuir; 2019 Feb; 35(8):3176-3182. PubMed ID: 30741550
[TBL] [Abstract][Full Text] [Related]
2. Graphene oxide nanoribbons exhibit significantly greater toxicity than graphene oxide nanoplatelets.
Chng EL; Chua CK; Pumera M
Nanoscale; 2014 Sep; 6(18):10792-7. PubMed ID: 25104246
[TBL] [Abstract][Full Text] [Related]
3. Consecutive evaluation of graphene oxide and reduced graphene oxide nanoplatelets immunotoxicity on monocytes.
Yan J; Chen L; Huang CC; Lung SC; Yang L; Wang WC; Lin PH; Suo G; Lin CH
Colloids Surf B Biointerfaces; 2017 May; 153():300-309. PubMed ID: 28285061
[TBL] [Abstract][Full Text] [Related]
4. Synergistic effect of shape-selective silver nanostructures decorating reduced graphene oxide nanoplatelets for enhanced cytotoxicity against breast cancer.
Derakhshi M; Ashkarran AA; Bahari A; Bonakdar S
Nanotechnology; 2018 Jul; 29(28):285102. PubMed ID: 29694332
[TBL] [Abstract][Full Text] [Related]
5. Site-specific delivery of a natural chemotherapeutic agent to human lung cancer cells using biotinylated 2D rGO nanocarriers.
Gupta N; Bhagat S; Singh M; Jangid AK; Bansal V; Singh S; Pooja D; Kulhari H
Mater Sci Eng C Mater Biol Appl; 2020 Jul; 112():110884. PubMed ID: 32409041
[TBL] [Abstract][Full Text] [Related]
6. Graphene oxide sensitizes cancer cells to chemotherapeutics by inducing early autophagy events, promoting nuclear trafficking and necrosis.
Lin KC; Lin MW; Hsu MN; Yu-Chen G; Chao YC; Tuan HY; Chiang CS; Hu YC
Theranostics; 2018; 8(9):2477-2487. PubMed ID: 29721093
[No Abstract] [Full Text] [Related]
7. Graphene Oxide Induced Perturbation to Plasma Membrane and Cytoskeletal Meshwork Sensitize Cancer Cells to Chemotherapeutic Agents.
Zhu J; Xu M; Gao M; Zhang Z; Xu Y; Xia T; Liu S
ACS Nano; 2017 Mar; 11(3):2637-2651. PubMed ID: 28208020
[TBL] [Abstract][Full Text] [Related]
8. Graphene oxide stabilized by PLA-PEG copolymers for the controlled delivery of paclitaxel.
Angelopoulou A; Voulgari E; Diamanti EK; Gournis D; Avgoustakis K
Eur J Pharm Biopharm; 2015 Jun; 93():18-26. PubMed ID: 25817600
[TBL] [Abstract][Full Text] [Related]
9. Anticancer activity of graphene oxide-reduced graphene oxide-silver nanoparticle composites.
Kavinkumar T; Varunkumar K; Ravikumar V; Manivannan S
J Colloid Interface Sci; 2017 Nov; 505():1125-1133. PubMed ID: 28704918
[TBL] [Abstract][Full Text] [Related]
10. Well-defined Graphene Oxide as a Potential Component in Lung Cancer Therapy.
Zuchowska A; Jastrzebska E; Mazurkiewicz-Pawlicka M; Malolepszy A; Stobinski L; Trzaskowski M; Brzozka Z
Curr Cancer Drug Targets; 2020; 20(1):47-58. PubMed ID: 31736445
[TBL] [Abstract][Full Text] [Related]
11. Folic acid-functionalized graphene oxide nanosheets via plasma etching as a platform to combine NIR anticancer phototherapy and targeted drug delivery.
Mauro N; Scialabba C; Agnello S; Cavallaro G; Giammona G
Mater Sci Eng C Mater Biol Appl; 2020 Feb; 107():110201. PubMed ID: 31761243
[TBL] [Abstract][Full Text] [Related]
12. Targeted delivery of SNX-2112 by polysaccharide-modified graphene oxide nanocomposites for treatment of lung cancer.
Liu X; Cheng X; Wang F; Feng L; Wang Y; Zheng Y; Guo R
Carbohydr Polym; 2018 Apr; 185():85-95. PubMed ID: 29421063
[TBL] [Abstract][Full Text] [Related]
13. One-pot exfoliation, functionalization, and size manipulation of graphene sheets: efficient system for biomedical applications.
Bani F; Bodaghi A; Dadkhah A; Movahedi S; Bodaghabadi N; Sadeghizadeh M; Adeli M
Lasers Med Sci; 2018 May; 33(4):795-802. PubMed ID: 29264722
[TBL] [Abstract][Full Text] [Related]
14. Formation of graphene oxide-hybridized nanogels for combinative anticancer therapy.
Xu X; Wang J; Wang Y; Zhao L; Li Y; Liu C
Nanomedicine; 2018 Oct; 14(7):2387-2395. PubMed ID: 28552643
[TBL] [Abstract][Full Text] [Related]
15. Combination of graphene oxide-silver nanoparticle nanocomposites and cisplatin enhances apoptosis and autophagy in human cervical cancer cells.
Yuan YG; Gurunathan S
Int J Nanomedicine; 2017; 12():6537-6558. PubMed ID: 28919753
[TBL] [Abstract][Full Text] [Related]
16. Intracellular localization and toxicity of graphene oxide and reduced graphene oxide nanoplatelets to mussel hemocytes in vitro.
Katsumiti A; Tomovska R; Cajaraville MP
Aquat Toxicol; 2017 Jul; 188():138-147. PubMed ID: 28521151
[TBL] [Abstract][Full Text] [Related]
17. Graphene oxide as a nanocarrier for controlled release and targeted delivery of an anticancer active agent, chlorogenic acid.
Barahuie F; Saifullah B; Dorniani D; Fakurazi S; Karthivashan G; Hussein MZ; Elfghi FM
Mater Sci Eng C Mater Biol Appl; 2017 May; 74():177-185. PubMed ID: 28254283
[TBL] [Abstract][Full Text] [Related]
18. Natural and synthetic polymer for graphene oxide mediated anticancer drug delivery-A comparative study.
Deb A; R V
Int J Biol Macromol; 2018 Feb; 107(Pt B):2320-2333. PubMed ID: 29055699
[TBL] [Abstract][Full Text] [Related]
19. GO-PEG as a drug nanocarrier and its antiproliferative effect on human cervical cancer cell line.
Bikhof Torbati M; Ebrahimian M; Yousefi M; Shaabanzadeh M
Artif Cells Nanomed Biotechnol; 2017 May; 45(3):568-573. PubMed ID: 27027552
[TBL] [Abstract][Full Text] [Related]
20. Cisplatin-induced self-assembly of graphene oxide sheets into spherical nanoparticles for damaging sub-cellular DNA.
Nandi A; Mallick A; More P; Sengupta P; Ballav N; Basu S
Chem Commun (Camb); 2017 Jan; 53(8):1409-1412. PubMed ID: 28079217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
